Amblyopia treatment: An evidence-based approach to maximising treatment outcome

Clinical and Experimental Optometry

Volumn 90, Issue 4, 2007, Pages 250-257

  Webber, Ann L ^a,b  

^a Queensland University of Technology ^*  (Australia)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Amblyopia; Anisometropia; Compliance; Disability; Natural history; Prevalence; Strabismus; Treatment

Indexed keywords

AGING; AMBLYOPIA; ARTICLE; CATARACT; CATARACT EXTRACTION; EMOTION; EVIDENCE BASED MEDICINE; HUMAN; PATIENT COMPLIANCE; PROTECTIVE CLOTHING; PSYCHOLOGICAL ASPECT; REFRACTION ERROR; STRABISMUS; TREATMENT OUTCOME;

AGING; AMBLYOPIA; CATARACT; CATARACT EXTRACTION; EMOTIONS; EVIDENCE-BASED MEDICINE; HUMANS; OCCLUSIVE DRESSINGS; PATIENT COMPLIANCE; REFRACTIVE ERRORS; STRABISMUS; TREATMENT OUTCOME;

EID: 34547368105     PISSN: 08164622     EISSN: 14440938     Source Type: Journal    
DOI: 10.1111/j.1444-0938.2007.00164.x     Document Type: Article

References (64)

1. Attebo K, Mitchell P, Cumming R, Smith W, Jolly N, Sparkes R. Prevalence and causes of amblyopia in an adult population. Ophthalmology 1998 105 : 154 159.
2. Brown SA, Weih LM, Fu CL, Dimitrov P, Taylor HR, McCarty CA. Prevalence of amblyopia and associated refractive errors in an adult population in Victoria, Australia. Ophthalmic Epidemiol 2000 7 : 249 258.
3. Rahi JS, Logan S, Timms C, Russell-Eggitt I, Taylor D. Risk, causes, and outcomes of visual impairment after loss of vision in the non-amblyopic eye: a population-based study. Lancet 2002 360 (9333 597 602.
4. Webber A, Wood J. Amblyopia: prevalence, natural history, functional effects and treatment. Clin Exp Optom 2005 88 : 365 375.
5. Simons K. Amblyopia characterization, treatment, and prophylaxis. Surv Ophthalmol 2005 50 : 123 166.
6. Daw NW. Visual Development, 2nd ed. New York : Springer Science+Business Media, Inc, 2006.
7. Thompson JR, Woodruff G, Hiscox F, Strong N, Minshull C. The incidence and prevalence of amblyopia detected in childhood. Public Health 1991 105 : 455 462.
8. The Pediatric Eye Disease Investigator Group. A prospective, pilot study of treatment of amblyopia in children 10 to <18 years old. Am J Ophthalmol 2004 137 : 581 583.
9. Clarke M, Wright C, Hrisos S, Anderson JD, Henderson SE, Richardson SR. Randomised controlled trial of treatment of unilateral visual impairment detected at preschool vision screening. BMJ 2003 327 : 1251 1254.
10. Richardson SR, Wright CM, Hrisos S, Buck D, Clarke MP. Stereoacuity in unilateral visual impairment detected at preschool screening: outcomes from a randomized controlled trial. Invest Ophthalmol Vis Sci 2005 46 : 150 154.
11. Simons KA, Preslan M. Natural history of amblyopia untreated owing to lack of compliance. Br J Ophthalmol 1999 83 : 582 587.
12. Hiscox F, Strong N, Thompson JR, Minshull C, Woodruff G. Occlusion for amblyopia: a comprehensive survey of outcome. Eye 1992 6 : 300 304.
13. Williamson T, Andrews R, Dutton GN, Murray G, Graham N. Assessment of an innercity visual screening programme for preschool children. Br J Ophthalmol 1995 79 : 1068 1073.
14. Hudak D, Magoon E. Poverty predicts amblyopia treatment failure. J AAPOS 1997 4 : 214 215.
15. Williams C, Northstone K, Harrad RA, Sparrow JM, Harvey I. Amblyopia treatment outcomes after preschool screening v school entry screening: observational data from a prospective cohort study. (Extended Report). Br J Ophthalmol 2003 87 : 988 994.
16. Eibschitz-Tsimhoni M, Friedman T, Naor J, Eibschita N, Friedman Z. Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia. J AAPOS 2000 4 : 194 199.
17. Bloch D, Wick B. Differences between strabismic and anisometropic amblyopia: Research findings and impact on management. Problems Optom 1991 3 : 276 292.
18. Moseley MJ, Neufeld M, McCarry B, Charnock A, McNamara R, Rice T, Fielder A. Remediation of refractive amblyopia by optical correction alone. Ophthalmic Physiol Opt 2002 22 : 296 299.
19. Stewart CE, Moseley MJ, Fielder AR, Stephens DA. MOTAS Cooperative Refractive adaptation in amblyopia: quantification of effect and implications for practice. Br J Ophthalmol 2004 88 : 1552 1556.
20. Repka MX, Holmes JM, Melia BM, Beck RW, Gearinger MD, Tamkins SM, Wheeler DT, Pediatric Eye Disease Investigator Group. The effect of amblyopia treatment on ocular alignment. J AAPOS 2006 9 : 542 545.
21. Steele AL, Bradfield Y, Kushner B, France TD, Struck M, Gangnon R. Successful treatment of anisometropic amblyopia with spectacles alone. J AAPOS 2006 10 : 37 43.
22. The Pediatric Eye Disease Investigator Group. Treatment of anisometropic amblyopia in children with refractive correction. Ophthalmology 2006 113 : 895 903.
23. Stewart CE, Moseley MJ, Stephens DA, Fielder AR. Treatment dose-response in amblyopia therapy: The Monitored Occlusion Treatment of Amblyopia Study (MOTAS). Invest Ophthalmol Vis Sci 2004 45 : 3048 3054.
24. Membreno JH, Brown MM, Brown GC, Sharma S, Beauchamp GR. A cost-utility analysis of therapy for amblyopia. Ophthalmology 2002 109 : 2265 2271.
25. Robaei D, Rose KA, Kifley A, Cosstick M, Ip JM, Mitchell P. Factors associated with childhood strabismus: findings from a population-based study. Ophthalmology 2006 113 : 1146 1153.
26. The Pediatric Eye Disease Investigator Group. The clinical profile of moderate amblyopia in children younger than 7 years. Arch Ophthalmol 2002 120 : 281 287.
27. The Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002 120 : 268 277.
28. Holmes JM, Kraker RT, Beck RW, Birch EE, Cotter SA, Everett DF, Hertle RW, Quinn GE, Repka MX, Scheiman MM, Wallace DK, Pediatric Eye Disease Investigator Group. A randomized trial of prescribed patching regimens for treatment of severe amblyopia in children. Ophthalmology 2003 110 : 2075 2087.
29. Repka MX, Cotter SA, Beck RW, Kraker RT, Birch EE, Everett DF, Hertle RW, Holmes JM, Quinn GE, Sala NA, Scheiman MM, Stager DR Sr., Wallace DK, Pediatric Eye Disease Investigator Group. A randomized trial of atropine regimens for treatment of moderate amblyopia in children. Ophthalmology 2004 111 : 2076 2085.
30. Holmes JM, Clarke MP. Amblyopia. Lancet 2006 367 : 1343 1351.
31. Epelbaum M, Milleret C, Buisseret P, Dufier JL. The sensitive period for strabismic amblyopia in humans. Ophthalmology 1993 100 : 323 327.
32. Mohan K, Saroha V, Sharma A. Successful occlusion therapy for amblyopia in 11- to 15-year-old children. J Pediatr Ophthalmol Strabismus 2004 41 : 89 95.
33. Klaeger-Manzanell C, Hoyt CS, Good WV. Two step recovery of vision in the amblyopic eye after visual loss and enucleation of the fixing eye. Br J Ophthalmol 1994 78 : 506 507.
34. Scheiman MM, Hertle RW, Beck RW, Edwards AR, Birch E, Cotter SA, Crouch ER Jr., Cruz OA, Davitt BV, Donahue S, Holmes JM, Lyon DW, Repka MX, Sala NA, Silbert DI, Suh DW, Tamkins SM, Pediatric Eye Disease Investigator Group. Randomized trial of treatment of amblyopia in children aged 7 to 17 years. Arch Ophthalmol 2006 123 : 437 447.
35. Holmes JM, Edwards AR, Beck RW, Arnold RW, Johnson DA, Klimek DL, Kraker RT, Lee KA, Lyon DW, Nosel ER, Repka MX, Sala NA, Silbert DI, Tamkins S, Pediatric Eye Disease Investigator Group. A randomized pilot study of near activities versus non-near activities during patching therapy for amblyopia. J AAPOS 2005 9 : 129 136.
36. Krumholtz I, FitzGerald D. Efficacy of treatment modalities in refractive amblyopia. JAOA 1999 70 : 399 404.
37. Waddingham PE, Butler TK, Cobb SV, Moody AD, Comaish IF, Haworth SM, Gregson RM, Ash IM, Brown SM, Eastgate RM, Griffiths GD. Preliminary results from the use of the novel Interactive Binocular Treatment (I-BiT[trade]) system in the treatment of strabismic and anisometropic amblyopia. Eye 2006 20 : 375 378.
38. McKee SP, Levi DM, Movshon JA. The pattern of visual deficits in amblyopia. J Vision 2003 3 : 380 405.
39. The Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with atropine in children: Experience of the Amblyopia Treatment Study. Am J Ophthalmol 2003 136 : 630 639.
40. The Pediatric Eye Disease Investigator Group. The course of moderate amblyopia treated with patching in children: Experience of the Amblyopia Treatment Study. Am J Ophthalmol 2003 136 : 620 629.
41. The Pediatric Eye Disease Investigator Group. A comparison of atropine and patching treatments for moderate amblyopia by patient age, cause of amblyopia, depth of amblyopia and other factors. Ophthalmology 2003 110 : 1632 1638.
42. Campos EC. Update on strabismus and amblyopia. Acta Ophthalmol Scand 1995 Suppl 214 : 17 24.
43. Holmes JM, Beck RW, Kraker RT, Astle WF, Birch EE, Cole SR, Cotter SA, Donahue S, Everett DF, Hertle RW, Keech RV, Paysse E, Quinn GF, Repka MX, Scheiman MM, Pediatric Eye Disease Investigator Group. Risk of amblyopia recurrence after cessation of treatment. J AAPOS 2004 8 : 420 428.
44. Rutstein RP, Corliss DA. Long-term changes in visual acuity and refractive error in amblyopes. Optom Vis Sci 2004 81 : 510 515.
45. Leiba H, Shimshoni M, Oliver M, Gottesman N, Levartovsky S. Long-term follow-up of occlusion therapy in amblyopia. Ophthalmology 2001 108 : 1552 1555.
46. Levartovsky S, Oliver M, Gottesman N, Shimshoni M. Long-term effect of hypermetropic anisometropia on the visual acuity of treated amblyopic eyes. Br J Ophthalmol 1998 82 : 55 58.
47. Lee SY, Isenberg SJ. The relationship between stereopsis and visual acuity after occlusion therapy for amblyopia. Ophthalmology 2003 110 : 2088 2092.
48. Searle A, Vedhara K, Norman P, Frost A, Harrad R. Compliance with eye patching in children and its psychosocial effects: A qualitative application of protection motivation theory. Psychol Health Med 2000 5 : 43 55.
49. Parkes LC. An investigation of the impact of occlusion therapy on children with amblyopia, its effect on their families, and compliance with treatment. Br Orthopt J 2001 58 : 30 37.
50. Smith KH, Baker DB, Keech RV, Adams LW, Rosa RH Jr., Austin CJ, Austin KM. Monocular congenital cataracts: psychological effects of treatment. J Pediatr Ophthalmol Strabismus 1991 28 : 245 249.
51. Koklanis K, Abel L, Aroni R. Psychosocial impact of amblyopia and its treatment: a multidisciplinary study. Clin Experiment Ophthalmol 2006 34 : 743 750.
52. Choong YF, Lukman H, Martin S, Laws DE. Childhood amblyopia treatment: psychosocial implications for patients and primary carers. Eye 2004 18 : 369 375.
53. Holmes JM, Beck RW, Kraker RT, Cole SR, Repka MX, Birch EE, Felius J, Christiansen SP, Coats DK, Kulp MT, Pediatric Eye Disease Investigator Group. Impact of patching and atropine treatment on the child and family in the amblyopia treatment study. Arch Ophthalmol 2003 121 : 1625 1632.
54. Clarke MP, Wright CM, Hrisos S, Anderson JD, Henderson J, Richardson SR. Emotional impact of amblyopia treatment on preschool children. BMJ 2003 327 (7426 1251.
55. Joy S, Davis H, Buckley D. Is stereopsis linked to hand-eye coordination? Br Orthopt J 2001 58 : 38 41.
56. Fielder AR, Irwin M, Auld R, Cocker KD, Jones HS, Moseley MJ. Compliance in amblyopia therapy: objective monitoring of occlusion. Br J Ophthalmol 1995 79 : 585 589.
57. Oliver M, Neumann MD, Chaimovitch Y, Gotesman N, Shimshoni M. Compliance and results of treatment for amblyopia in children more than 8 years old. Am J Ophthalmol 1986 102 : 340 345.
58. Nucci P, Alfarano R, Piantanida A, Brancato R. Compliance in anti-amblyopia occlusion therapy. Acta Ophthalmol Scand 1992 70 : 128 131.
59. Smith LK, Thompson JR, Woodruff G, Hiscox F. Factors affecting treatment compliance in amblyopia. J Pediatr Ophthalmol Strabismus 1995 32 : 98 101.
60. Newsham D. Parental non-concordance with occlusion therapy. Br J Ophthalmol 2000 84 : 957 962.
61. Searle A, Norman P, Harrad R, Vedhara K. Psychosocial and clinical determinants of compliance with occlusion therapy for amblyopic children. Eye 2002 16 : 150 155.
62. Edelman PM. Common pitfalls in amblyopia management. Am Orthopt J 1989 39 : 57 61.
63. Beardsell R, Clarke S, Mill M. Outcome of occlusion treatment for amblyopia. J Pediatr Ophthalmol Strabismus 1999 36 : 19 24.
64. Newsham D. A randomised controlled trial of written information: the effect on parental non-concordance with occlusion therapy. Br J Ophthalmol 2002 86 : 787 791.